SARS: Pharmacotherapy

Respirology

Volumn 8, Issue , 2003, Pages

  Tsang, Kenneth ^a   Zhong, Nan Shan ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Anti viral therapy; Corticosteroid; Ribavirin; Ritonavir and lopinavir; Severe acute respiratory syndrome; Treatment

Indexed keywords

GLYCYRRHIZIC ACID; HYDROCORTISONE; IMMUNOGLOBULIN G; LOPINAVIR PLUS RITONAVIR; METHYLPREDNISOLONE; PENTOXIFYLLINE; PREDNISOLONE; RECOMBINANT INTERFERON; RIBAVIRIN; STEROID;

ABDOMINAL PAIN; ALOPECIA; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTIFICIAL VENTILATION; ASTHENIA; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DRUG PULSE THERAPY; DRY SKIN; DYSPNEA; FLU LIKE SYNDROME; HEADACHE; HONG KONG; HUMAN; HYPERGLYCEMIA; HYPERURICEMIA; INSOMNIA; IRRITABILITY; LOW DRUG DOSE; LUNG FIBROSIS; NAUSEA; PANCREATITIS; PARESTHESIA; PHARYNGITIS; PLASMAPHERESIS; PNEUMONIA; PRIORITY JOURNAL; PRURITUS; RASH; RETICULOCYTOSIS; REVIEW; RHINITIS; SEVERE ACUTE RESPIRATORY SYNDROME; SIDE EFFECT; SLEEP DISORDER; STEROID THERAPY; SUPERINFECTION; TASTE DISORDER; THORAX PAIN; THYROID DISEASE; TREATMENT OUTCOME; VIRUS REPLICATION; VISUAL IMPAIRMENT; VOMITING;

ALGORITHMS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; DRUG COMBINATIONS; HUMANS; PYRIMIDINONES; RIBAVIRIN; RITONAVIR; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 0345732172     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1843.2003.00525.x     Document Type: Review

References (29)

1. Lam MF, Ooi GC, Lam B et al. An indolent case of severe acute respiratory syndrome (SARS). Am. J. Respir. Crit. Care Med. 2003; in press.
2. Tsang KW & Lam WK. Management of severe acute respiratory syndrome: the Hong Kong University experience. Am. J. Respir. Crit. Care Med. 2003; 168: 417-24.
3. Peiris JSM, Chu CM, Cheng VCC et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003; 361: 1767-72.
4. Tsang KW, Ho PL, Ooi GC et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 2003; 348: 1977-85.
5. Ooi GC, Khong PL, Ho JC et al. The prognostic significance of radiographic evaluation in severe acute respiratory syndrome (SARS). Radiology 2003; in press.
6. Nicholls JM, Poon LL, Lee KC et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003; 361: 1773-8.
7. Niederman MS, Mandell LA, Anzueto A et al. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am. J. Respir. Crit. Care Med. 2001; 163: 1730-54.
8. European Respiratory Socity. Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. Eur. Respir. J. 1998; 11: 986-91.
9. British Thoracic Society Standards of Care Committee. BTS Guidelines for the management of community acquired pneumonia in adults. Thorax 2001; 56 (Suppl. 4): IV1-64.
10. Wong GW & Hui DS. Severe acute respiratory syndrome (SARS): epidemiology, diagnosis and management. Thorax 2003; 58: 558-60.
11. Wenzel RP & Edmond MB. Managing SARS amidst uncertainty. N. Engl. J. Med. 2003; 348: 1947-8.
12. Cyranoski D. Critics slam treatment for SARS as ineffective and perhaps dangerous. Nature 2003; 423: 4.
13. Ho JC, Ooi GC, Mok TY et al. High dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. Am. J. Respir. Crit. Care Med. 2003, August 28 (Epub ahead of print).
14. Booth CM, Matukas LM, Tomlinson GA et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003; 289: 2801-9.
15. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Treatment of SARS with human interferons. Lancet 2003; 362: 293-4.
16. Martin B, Jimenez JL, Munoz-Fernandez A. Pentoxifylline and severe acute respiratory syndrome (SARS): a drug to be considered. Med. Sci. Monit. 2003; 9: SR29-34.
17. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 2003; 361: 2045-6.
18. Kontoyiannis DP, Pasqualini R, Arap W. Aminopeptidase N Inhibitors and SARS. Lancet 2003; 361: 1558.
19. Jia W & Gao W. Is traditional Chinese medicine useful in the treatment of SARS? Phytother. Res. 2003; 17: 840-1.
20. Zheng ZG & Zhong NS. The use of corticosteroid in management of critical SARS. Chin. Med. J. 2003; 42: 676-7.
21. Zhong NS & Zeng GQ. Our strategies for fighting severe acute respiratory syndrome (SARS). Am. J. Respir. Crit. Care Med 2003; 168: 7-9.
22. Tsang KW, Mok TY, Wong PC, Ooi GC. Severe acute respiratory syndrome (SARS) in Hong Kong, Respirology 2003; 8: 259-65.
23. Lee N, Hui D, Wu A et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 2003; 348: 1986-94.
24. So LK, Lau AC, Yam LY et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003; 361: 1615-7.
25. Wang H, Ding Y, Li X, Yang L, Zhang W, Kang W. Fatal aspergillosis in a patient with SARS who was treated with corticosteroids. N. Engl. J. Med. 2003; 349: 507-8.
26. Wang GF. On cortiosteroid therapy of SARS. Chin. Med. J. 2003; 42: 682-3.
27. Zhong NS. Management of SARS. In: Chinese Medical Forum SARS, Beijing, September 9 2003.
28. Guangdong Working Guideline for SARS Management and Prevention. Diagnosis criteria for critical SARS. In: Guangdong Working Guideline for SARS Management and Prevention, April 2003.
29. Zheng ZG, Chen RC, Li YM et al. Cohort analysis of secondary lower respiratory tract infection in SARS. Chin. J. Respir. Crit. Care Med. 2003; 2: 270-4.